COVID-19 deaths in people with intellectual disability in the UK and Ireland: descriptive study

Bhathika Perera1, Richard Laugharne2, William Henley3

  • 1Barnet Enfield and Haringey Mental Health Trust, UK.

Bjpsych Open
|October 16, 2020
PubMed

Insights

People with intellectual disability (ID) who died from COVID-19 were younger and had higher rates of comorbidities like epilepsy and Down syndrome. Understanding these specific risk factors is crucial for targeted prevention strategies in this vulnerable population.

Area of Science:

  • Public Health
  • Epidemiology
  • Intellectual Disability Research

Background:

  • Coronavirus disease 2019 (COVID-19) has disproportionately impacted individuals with intellectual disability.
  • Limited data exists on specific risk factors contributing to COVID-19 mortality in this population.
  • Identifying high-risk individuals is essential for developing targeted prevention strategies.

Purpose of the Study:

  • To identify comorbidities, demographic, and clinical factors associated with COVID-19 deaths in individuals with intellectual disability.
  • To compare risk factors between mild and moderate-to-profound intellectual disability subcohorts.

Main Methods:

  • An observational descriptive case series was conducted.
  • Data from 66 COVID-19 deaths in individuals with intellectual disability were analyzed.
  • Specific risk factors and comorbidities were examined, alongside comparisons between intellectual disability severity groups.

Main Results:

  • The study analyzed data from 66 deaths in individuals with intellectual disability.
  • This group was younger (mean age 64) than the general population COVID-19 death cohort.
  • High rates of moderate-to-profound intellectual disability, epilepsy, mental illness, dysphagia, Down syndrome, and dementia were observed.

Conclusions:

  • This is the first study to explore associations between risk factors and comorbidities in COVID-19 deaths among people with intellectual disability.
  • Findings offer insights into potential factors influencing mortality in this group.
  • Variations between intellectual disability severity groups highlight the need for further research into cumulative impacts and potential COVID-19 resurgence prevention.
Abstract

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Intellectual Disability01:29

Intellectual Disability

Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Learning Disabilities01:25

Learning Disabilities

Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...